Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-14 | MYRIAD GENETICS INC | Muzzey Dale
(Chief Scientific Officer) |
F | Common Stock | D | 940 | $19.55 - $19.55 | $18,377 |
2024-04-14 | MYRIAD GENETICS INC | Verratti Mark
(Chief Commercial Officer) |
F | Common Stock | D | 1076 | $19.55 - $19.55 | $21,035 |
2024-04-06 | MYRIAD GENETICS INC | Munk Natalie
(Chief Accounting Officer) |
F | Common Stock | D | 581 | $20.26 - $20.26 | $11,771 |
2024-03-14 | MYRIAD GENETICS INC | Leffler Scott J.
(Chief Financial Officer) |
A | Common Stock | A | 46905 | $0.00 - $0.00 | $0 |
2024-03-25 | MYRIAD GENETICS INC | Munk Natalie
(Chief Accounting Officer) |
F | Common Stock | D | 363 | $21.98 - $21.98 | $7,978 |
2024-03-15 | MYRIAD GENETICS INC | Wong Pamela
(Chief Legal Officer) |
F | Common Stock | D | 2568 | $21.16 - $21.16 | $54,338 |
2024-03-14 | MYRIAD GENETICS INC | Munk Natalie
(Chief Accounting Officer) |
A | Common Stock | A | 7500 | $0.00 - $0.00 | $0 |
2024-03-15 | MYRIAD GENETICS INC | Ancona Margaret
(SVP, Chief of Staff) |
F | Common Stock | D | 1585 | $21.16 - $21.16 | $33,538 |
2024-03-14 | MYRIAD GENETICS INC | Ancona Margaret
(SVP, Chief of Staff) |
A | Common Stock | A | 35178 | $0.00 - $0.00 | $0 |
2024-03-15 | MYRIAD GENETICS INC | Haas Kevin Richard
(Chief Technology Officer) |
F | Common Stock | D | 3306 | $21.16 - $21.16 | $69,954 |
2024-03-14 | MYRIAD GENETICS INC | Haas Kevin Richard
(Chief Technology Officer) |
A | Common Stock | A | 35178 | $0.00 - $0.00 | $0 |
2024-03-14 | MYRIAD GENETICS INC | Solaiman Shereen
(Chief People Officer) |
A | Common Stock | A | 41042 | $0.00 - $0.00 | $0 |
2024-03-15 | MYRIAD GENETICS INC | Muzzey Dale
(Chief Scientific Officer) |
F | Common Stock | D | 3322 | $21.16 - $21.16 | $70,293 |
2024-03-14 | MYRIAD GENETICS INC | Muzzey Dale
(Chief Scientific Officer) |
A | Common Stock | A | 49250 | $0.00 - $0.00 | $0 |
2024-03-01 | MYRIAD GENETICS INC | Solaiman Shereen
(Chief People Officer) |
F | Common Stock | D | 1108 | $22.18 - $22.18 | $24,575 |
2024-01-29 | MYRIAD GENETICS INC | Leffler Scott J.
(Chief Financial Officer) |
A | Common Stock | A | 117770 | $0.00 - $0.00 | $0 |
2024-01-01 | MYRIAD GENETICS INC | Muzzey Dale
(Chief Scientific Officer) |
F | Common Stock | D | 303 | $19.14 - $19.14 | $5,799 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |